Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer

Older women are poorly represented in trials evaluating chemotherapy for breast cancer. Population-based analysis of the SEER database found that women aged 70 years or older could achieve good survival after chemotherapy for non-metastatic breast cancer. Those with HER2-positive disease had superior survival, reinforcing benefit in this population.